| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 03/24/2011 | WO2010091381A3 An intermittent dosing strategy for treating rheumatoid arthrtis |
| 03/24/2011 | US20110071211 MicroRNA (miRNA) And Downstream Targets For Diagnostic And Therapeutic Purposes |
| 03/24/2011 | US20110071182 Inhibitors of AKT Activity |
| 03/24/2011 | US20110071179 Macrocyclic inhibitors of jak |
| 03/24/2011 | US20110071162 Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 03/24/2011 | US20110071161 Triazolopyridine carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 03/24/2011 | US20110071145 Raf Modulators And Methods Of Use |
| 03/24/2011 | US20110071144 Quinazoline derivatives and pharmaceutical compositions containing them |
| 03/24/2011 | US20110071143 Fused triazole amines as p2x7 modulators |
| 03/24/2011 | US20110071139 Cycloalkyl Lactame Derivatives As Inhibitors Of 11-Beta-Hydroxysteroid Dehydrogenase 1 |
| 03/24/2011 | US20110071134 2-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases |
| 03/24/2011 | US20110071133 Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 03/24/2011 | US20110071104 Methods for Treating Osteoarthritis |
| 03/24/2011 | US20110071098 Flurbiprofen and muscle relaxant gel combinations thereof |
| 03/24/2011 | US20110071095 Compositions and Methods for Increasing Telomerase Activity |
| 03/24/2011 | US20110071092 Anti-inflammatory compounds and uses thereof |
| 03/24/2011 | US20110071087 Polypeptides having modulatory effects on cells |
| 03/24/2011 | US20110071081 Methods useful in the treatment of bone resorption diseases |
| 03/24/2011 | US20110070291 Food or beverage composition fortified with thyronamines and/or thyronamine precursors |
| 03/24/2011 | US20110070282 Materials and Methods for Treating Skeletal System Damage and Promoting Skeletal System Repair and Regeneration |
| 03/24/2011 | US20110070281 Reparative cell delivery via hyaluronic acid vehicles |
| 03/24/2011 | US20110070276 Bioactive keratin peptides |
| 03/24/2011 | US20110070271 Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles |
| 03/24/2011 | US20110070237 Methods of modulating and identifying agents that modulate intracellular calcium |
| 03/24/2011 | US20110070233 Actriib antagonists and dosing and uses thereof |
| 03/24/2011 | CA2773125A1 Compounds having tafia inhibitory activity |
| 03/24/2011 | CA2772689A1 Glycine compound |
| 03/23/2011 | EP2298812A2 Remedies for juvenile chronic arthritis and related diseases |
| 03/23/2011 | EP2298803A2 Human G-protein coupled receptor and ligands thereof |
| 03/23/2011 | EP2298769A1 Xanthin derivatives, their production and utilisation as medicine |
| 03/23/2011 | EP2298747A1 Triazole derivative or salt thereof |
| 03/23/2011 | EP2298355A2 Albumin fusion proteins |
| 03/23/2011 | EP2298354A2 Remodelling and glycoconjugation of interferon-beta |
| 03/23/2011 | EP2298335A1 Use of morphogenic proteins for treating cartilage defects |
| 03/23/2011 | EP2298308A2 Integrin-binding small molecules |
| 03/23/2011 | EP2298300A1 Compositions for inhibition of anglogenesis comprising thalidomide and aspirin |
| 03/23/2011 | EP2297183A1 Treatment for diseases relying on discovery that thioredoxin mediates nitric oxide release in cells |
| 03/23/2011 | EP2297162A1 Compounds |
| 03/23/2011 | EP2297154A1 1- (7-(hexahydropyrrolo [3, 4-c]pyrrol-2 (1h) -yl) quin0lin-4-yl) -3- (pyrazin-2-yl) urea derivatives and related compounds as glycogen synthase kinase 3 (gsk-3) |
| 03/23/2011 | EP2297137A1 Novel heteroaryl carboxamide derivatives |
| 03/23/2011 | EP2297100A1 Tetrahydrocyclopentaýb¨indole androgen receptor modulators |
| 03/23/2011 | EP1469878B1 Fgfr agonists |
| 03/23/2011 | EP1448205B1 Combinations for the treatment of immunoinflammatory disorders |
| 03/23/2011 | EP1351707B1 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
| 03/23/2011 | EP1278748B1 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 03/23/2011 | CN201767299U Pillow for beauty |
| 03/23/2011 | CN1843393B Use of pharmaceutical composition containing aceglutamide and safflower |
| 03/23/2011 | CN101987189A Detoxifying and channel dredging external application powder |
| 03/23/2011 | CN101987161A Traditional Chinese medicine for treating diabetic gout |
| 03/23/2011 | CN101987150A Chinese medicinal herb preparation for treating gout and preparation method thereof |
| 03/23/2011 | CN101987129A Chinese medicine preparation for treating osteomyelitis |
| 03/23/2011 | CN101987123A Medicament for easing pain of human body and preparation method thereof |
| 03/23/2011 | CN101987118A Food therapy health care wine for treating rheumatoid diseases and rheumatism |
| 03/23/2011 | CN101987095A Application of daphnetin to preparation of medicament for treating rheumatism, rheumatoid arthritis and sprain caused by falling |
| 03/23/2011 | CN101987088A Preparation and applications of paeonol controlled-release preparation |
| 03/23/2011 | CN101987053A Natural mineral traditional Chinese medicinal hot pack |
| 03/23/2011 | CN101856457B Medicine with kidney tonifying, essence replenishing and yang invigorating functions and preparation method thereof |
| 03/23/2011 | CN101716317B Orally taken and externally applied traditional Chinese medicine composite for treating rheumatoid arthritis |
| 03/23/2011 | CN101698033B Big plaster for treating various rheumatic osteopathy and traumatic injuries |
| 03/23/2011 | CN101618186B Traditional Chinese medicine prescription for treating arthritis |
| 03/23/2011 | CN101596295B Medicinal composition for treating gout and preparation process thereof |
| 03/23/2011 | CN101543492B Novel application of dendrobine |
| 03/23/2011 | CN101396437B Anti-gout drop pills of pure traditional Chinese medicine |
| 03/23/2011 | CN101352506B Medicament for treating orthopedic disorders and preparation method and use thereof |
| 03/23/2011 | CN101274000B Medicine use of herb aralia elata seem |
| 03/23/2011 | CN101224200B Novel anti-systematic erythema lupus medicine |
| 03/23/2011 | CN101199783B Heat-transfer dose medicament for treating soft tissue scathing |
| 03/23/2011 | CN101181560B Medicine for treating tongluozhitong of rheumatoid arthritis |
| 03/23/2011 | CN101168041B Rheumatism treating medicine |
| 03/23/2011 | CN101085357B Non-virus nano nucleic acid transferring composite for curing gristle defection by injecting in joint cavity and preparing method thereof |
| 03/23/2011 | CN101062145B Health drug pillow |
| 03/22/2011 | US7910709 Thyroid stimulating hormone for use in diagnosis, prevention and treatment of thyroid gland disorders |
| 03/22/2011 | US7910617 Method for suppressing the number of peripheral blood lymphocytes using an amino alcohol compound |
| 03/22/2011 | US7910605 Administering tertiary amines, e.g., 3,3-Dimethylbutyl 3-piperidinopropyl ether, 3-Phenylpropyl 3-piperidinopropyl ether, or3-(4-Chlorophenyl)propyl 3-piperidinopropyl ether to treat cognitive disorders such as attention, wakefulness and memory disorders |
| 03/22/2011 | US7910567 Opticin nucleic acid administration reduces blood vessel formation |
| 03/22/2011 | US7910542 Methods for promoting wound healing and muscle regeneration with the cell signaling protein Nell1 |
| 03/22/2011 | CA2492342C Novel bio-active pyrimidine derivatives |
| 03/22/2011 | CA2488001C 1,5-distributed pyrrolid-2-one derivatives for use as ep4 receptor agonists in the treatment of eye diseases such as glaucoma |
| 03/22/2011 | CA2480273C Ph-sensitive polymer |
| 03/22/2011 | CA2479363C Thiopyrimidine and isothiazolopyrimidine kinase inhibitors |
| 03/22/2011 | CA2471538C Pyrrolopyrimidines |
| 03/22/2011 | CA2445333C Quinoline derivatives and quinazoline derivatives having azolyl group |
| 03/22/2011 | CA2433675C Pharmaceutically active piperidine derivatives |
| 03/22/2011 | CA2396519C A process for isolation of osteopontin from milk |
| 03/22/2011 | CA2359334C Bifidobacterium in the treatment of inflammatory disease |
| 03/17/2011 | WO2011032175A1 Combination formulations of tranilast and allopurinol and methods related thereto |
| 03/17/2011 | WO2011031901A1 Actriib antagonists and dosing and uses thereof |
| 03/17/2011 | WO2011031856A1 Bmp -7 for use in treating pain induced by injuries and diseases of an articular joint |
| 03/17/2011 | WO2011031601A2 Nutritional compositions including exogenous vitamin k2 |
| 03/17/2011 | WO2011031525A1 Osteolysis treatment |
| 03/17/2011 | WO2011030873A1 Benzyl compounds |
| 03/17/2011 | WO2011030868A1 Substituted carbonyl compounds |
| 03/17/2011 | WO2011030865A1 Substituted zenzyl compounds |
| 03/17/2011 | WO2011030774A1 Pth-containing therapeutic/prophylactic agent for osteoporosis, characterized in that pth is administered once a week at unit dose of 100 to 200 units |
| 03/17/2011 | WO2011030021A1 Animal or human health food supplement for relieving and supporting joints |
| 03/17/2011 | WO2011029404A1 Mir-125a for regulating expression of rantes, composition and use thereof |
| 03/17/2011 | US20110065918 New phenylalanine derivatives |
| 03/17/2011 | US20110065800 Formulations for cathepsin k inhibitors |
| 03/17/2011 | US20110065772 Treatment of rheumatoid arthritis |
| 03/17/2011 | US20110065768 Non-steroidal androgens compounds |